/
RSS Feed
Deepak Bhatt, Cleveland Clinic, Ohio
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The idea of adding clopidogrel anti-platelet therapy to standard aspirin therapy among patients with multiple risk factors for coronary disease is not supported by the CHARISMA study findings reported at the ACC conference in Atlanta. But Audio Medica heard from Deepak Bhatt of the Cleveland Clinic that the study found patients with established cardiovascular disease can benefit.
[audio:https://www.audiomedica.com/podcasting/acc2006/deepak_bhatt.mp3] American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The idea of adding clopidogrel anti-platelet therapy to standard aspirin therapy among patients with multiple risk factors for coronary disease is not supported by the CHARISMA study findings reported at the ACC conference in Atlanta. But Audio Medica heard from Deepak Bhatt of the Cleveland Clinic that the study found patients with established cardiovascular disease can benefit.
